| LEAP - Where Disease Management Begins with Disease, not Data |
 |
Hole In IBS Treatment Guidelines -
What To Do About Diet?
(2/6)
IBS can be one of the more challenging chronic conditions
to treat clinically, especially for moderate to severe cases.
After diagnosis, reassurance and pharmacotherapy for symptomatic
relief is the treatment of choice for most physicians. While
traditional medications have shown an ability to decrease
specific GI symptoms, they have failed to have an impact
on global
symptoms, a fundamental measure of IBS therapy
effectiveness.
|
| The Clinical Guidelines from the National Guideline Clearinghouse are derived from the Position Statement for IBS treatment set forth by the American Gastroenterological Association. They state under the General Treatment Approach “…the physician should establish an effective therapeutic relationship, provide patient education and reassurance, and help with dietary and lifestyle modifications when needed”. Concerned physicians are left to ponder, “How exactly do I help with dietary modifications?” as there are no clear guidelines. The answer to this question lies in a deeper understanding of the reference in the Merck Manual of Diagnosis to a population of IBS patients whose “IBS was provoked by Food Intolerance” and the concept of global symptomology in IBS, both as a clinical feature and basis for outcome assessment. | |
|
|
